Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Maximum Tolerated Dose × Other solid neoplasm × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1 Other solid neoplasm 1 Gynecologic 1

Conditions

Advanced Solid Tumors 1

Interventions

Cisplatin 67 Paclitaxel 65 Carboplatin 60 pembrolizumab 56 Irinotecan 54 Gemcitabine 52 Injections 43 Docetaxel 42 Cyclophosphamide 34 Pemetrexed 31 Fluorouracil 31 Oxaliplatin 28 Capecitabine 28 Bevacizumab 28 Leucovorin 24 Nivolumab 21 tislelizumab 19 atezolizumab 19 Etoposide 17 Temozolomide 16 Cetuximab 16 Bortezomib 15 durvalumab 14 Topotecan 14 Sorafenib 14 Erlotinib Hydrochloride 14 olaparib 13 fludarabine 13 alvocidib 13 Taxes 12

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02994953 2024-09-20

COMBO

EMD Serono

Phase 1 Terminated

52 enrolled 34 charts

Other solid neoplasm

Advanced Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡